Brian W. Hanak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brian W. Hanak has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Samuel R. Browd
4 shared publicationsWilliam Shain
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
3 shared publications- Brian Vala Nahed
Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA
2 shared publications Carolyn A. Harris
Department of Neurosurgery, Wayne State University and Children’s Hospital of Michigan, Detroit, MI, USA
2 shared publications- Edina Amalia Wappler-Guzzetta
Department of Pathology and Laboratory Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA 02118, USA
2 shared publications - Firas Bannout
Department of Neurology, Loma Linda University Medical Center, Loma Linda, USA
2 shared publications
Latest Publications
- 21 August 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Beyond structural fragility in germinal matrix hemorrhage: A protease-threshold model of developmental cerebral microvascular failure
Germinal matrix hemorrhage (GMH) is a localized form of developmental cerebral microvascular failure and a major cause of mortality and long-term neurological disability in preterm infants. The GM is a highly angiogenic, protease-active developmental niche that operates near the limits of vascular stability under tightly regulated intrauterine conditions. Preterm birth disrupts this balance by removing late-gestational immune modulation and exposing protease-primed GM vessels to exaggerated inflammatory activation. Dysregulated innate immune responses amplify endothelial junctional cleavage and basement-membrane degradation and reprogram the local myeloid environment toward neutrophil-derived protease release. We propose a unified protease-threshold framework in which GMH occurs when inflammatory amplification drives proteolytic activity beyond the structural resilience of the immature GM vasculature. This model may help account for the timing, localization, and heterogeneity of GMH and provides a testable framework for studying developmental neurovascular vulnerability, biomarker discovery, and preventive strategies.
- 21 August 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Beyond structural fragility in germinal matrix hemorrhage: A protease-threshold model of developmental cerebral microvascular failure
Germinal matrix hemorrhage (GMH) is a localized form of developmental cerebral microvascular failure and a major cause of mortality and long-term neurological disability in preterm infants. The GM is a highly angiogenic, protease-active developmental niche that operates near the limits of vascular stability under tightly regulated intrauterine conditions. Preterm birth disrupts this balance by removing late-gestational immune modulation and exposing protease-primed GM vessels to exaggerated inflammatory activation. Dysregulated innate immune responses amplify endothelial junctional cleavage and basement-membrane degradation and reprogram the local myeloid environment toward neutrophil-derived protease release. We propose a unified protease-threshold framework in which GMH occurs when inflammatory amplification drives proteolytic activity beyond the structural resilience of the immature GM vasculature. This model may help account for the timing, localization, and heterogeneity of GMH and provides a testable framework for studying developmental neurovascular vulnerability, biomarker discovery, and preventive strategies.
- Open Access
- 31 January 2024
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 3 (1) , 1
Correction: Neuropathologic findings in a patient with Parry-Romberg syndrome: active cerebral vasculitis and brain injury
- 31 January 2024
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 3 (1) , 1
Open AccessCorrection: Neuropathologic findings in a patient with Parry-Romberg syndrome: active cerebral vasculitis and brain injury
- Open Access
- 6 January 2024
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 3 (1) , 1-8
Neuropathologic findings in a patient with Parry-Romberg syndrome: active cerebral vasculitis and brain injury
Purpose: Parry-Romberg syndrome (PRS) is a rare disorder characterized by slowly progressive hemifacial atrophy. Although the underlying etiology is unknown, proposed disease mechanisms which include autoimmune, infection, trauma, and other causes have been proposed as underlying disease mechanisms. Approximately, 10–20% of PRS patients have neurologic manifestations such as epilepsy, headaches, or associated vascular malformations. There are reports of PRS responsive to immunosuppressive medications, supporting the autoimmune hypothesis. Currently, the neuropathologic findings in patients with PRS are not well documented. Methods: Herein, we present a case of a 19-year-old female with PRS, who underwent partial frontal lobectomy for intractable epilepsy. Results: The resection specimen showed multifocal active lymphocytic (T-cell mediated) arteritis in midsized cortical arterioles, with the adjacent meninges showing fibrosis involving both the meningeal tissue and its vascular network. In addition, neuronal loss and gliosis were evident in the cortex, likely due to the associated vascular injury. Conclusions: This report is the first to demonstrate active cerebral vasculitis in a patient with PRS, supporting the previous suspicion of inflammatory etiology in this disease. In addition, the widespread vascular fibrosis in the meningeal vessels and an area of cortical ischemia support the presence of previous inflammatory vascular processes in the area.
- 6 January 2024
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 3 (1) , 1-8
Open AccessNeuropathologic findings in a patient with Parry-Romberg syndrome: active cerebral vasculitis and brain injury
Purpose: Parry-Romberg syndrome (PRS) is a rare disorder characterized by slowly progressive hemifacial atrophy. Although the underlying etiology is unknown, proposed disease mechanisms which include autoimmune, infection, trauma, and other causes have been proposed as underlying disease mechanisms. Approximately, 10–20% of PRS patients have neurologic manifestations such as epilepsy, headaches, or associated vascular malformations. There are reports of PRS responsive to immunosuppressive medications, supporting the autoimmune hypothesis. Currently, the neuropathologic findings in patients with PRS are not well documented. Methods: Herein, we present a case of a 19-year-old female with PRS, who underwent partial frontal lobectomy for intractable epilepsy. Results: The resection specimen showed multifocal active lymphocytic (T-cell mediated) arteritis in midsized cortical arterioles, with the adjacent meninges showing fibrosis involving both the meningeal tissue and its vascular network. In addition, neuronal loss and gliosis were evident in the cortex, likely due to the associated vascular injury. Conclusions: This report is the first to demonstrate active cerebral vasculitis in a patient with PRS, supporting the previous suspicion of inflammatory etiology in this disease. In addition, the widespread vascular fibrosis in the meningeal vessels and an area of cortical ischemia support the presence of previous inflammatory vascular processes in the area.
- Open Access
- 25 May 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (21)
Lipid Deposition Profiles Influence Foreign Body Responses (Adv. Mater. 21/2023)
- 25 May 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (21)
Open AccessLipid Deposition Profiles Influence Foreign Body Responses (Adv. Mater. 21/2023)
- 24 September 2020
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 20 (2) , 183-188
Manual Shunt Connector Tool to Aid in No-Touch Technique
BACKGROUND: Given the morbidity and cost associated with cerebrospinal fluid shunt infections, many neurosurgical protocols implement “no-touch” technique to minimize infection. However, current surgical tools are not designed specifically for this task and surgeons often resort to using their hands to connect the shunt catheter to the valve. OBJECTIVE: To develop an efficient and effective shunt assembly tool. METHODS: Prototypes were designed using computer assisted software and machined in stainless steel. The amount of time and number of attempts it took volunteers to connect a Bacticel shunt catheter to a Delta valve were recorded using the new tool and standard shodded mosquitos. Scanning electron microscopy (SEM) was done on manipulated catheters to assess potential damage. Practicing neurosurgeons provided feedback. RESULTS: Nonsurgeon (n = 13) volunteers and neurosurgeons (n = 6) both completed the task faster and with fewer attempts with the new tool (mean 7.18 vs 15.72 s and 2.00 vs 6.36 attempts, P < .0001; mean 2.93 vs 5.96 s and 1.06 vs 2.94 attempts, P < .001, respectively). SEM of 24 manipulated catheters showed no microscopic damage. 100% of neurosurgeons surveyed (n = 10) would adapt the tool in their practice, 90% preferred use of the new tool compared to their existing method, and 100% rated it easier to use compared to existing instruments. CONCLUSION: The new tool shortened the time and number of attempts to connect a shunt catheter to a valve. Neurosurgeons preferred the new tool to existing instruments. There was no evidence of catheter damage with the use of this tool.
- 24 September 2020
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 20 (2) , 183-188
Manual Shunt Connector Tool to Aid in No-Touch Technique
BACKGROUND: Given the morbidity and cost associated with cerebrospinal fluid shunt infections, many neurosurgical protocols implement “no-touch” technique to minimize infection. However, current surgical tools are not designed specifically for this task and surgeons often resort to using their hands to connect the shunt catheter to the valve. OBJECTIVE: To develop an efficient and effective shunt assembly tool. METHODS: Prototypes were designed using computer assisted software and machined in stainless steel. The amount of time and number of attempts it took volunteers to connect a Bacticel shunt catheter to a Delta valve were recorded using the new tool and standard shodded mosquitos. Scanning electron microscopy (SEM) was done on manipulated catheters to assess potential damage. Practicing neurosurgeons provided feedback. RESULTS: Nonsurgeon (n = 13) volunteers and neurosurgeons (n = 6) both completed the task faster and with fewer attempts with the new tool (mean 7.18 vs 15.72 s and 2.00 vs 6.36 attempts, P < .0001; mean 2.93 vs 5.96 s and 1.06 vs 2.94 attempts, P < .001, respectively). SEM of 24 manipulated catheters showed no microscopic damage. 100% of neurosurgeons surveyed (n = 10) would adapt the tool in their practice, 90% preferred use of the new tool compared to their existing method, and 100% rated it easier to use compared to existing instruments. CONCLUSION: The new tool shortened the time and number of attempts to connect a shunt catheter to a valve. Neurosurgeons preferred the new tool to existing instruments. There was no evidence of catheter damage with the use of this tool.
- 1 April 2018
- Published by Elsevier in World Neurosurgery
- Vol. 112, 161-165
Rapid Intraoperative in Situ Synthetic Cranioplasty
- 1 April 2018
- Published by Elsevier in World Neurosurgery
- Vol. 112, 161-165
Rapid Intraoperative in Situ Synthetic Cranioplasty
- 22 February 2018
- Published by Elsevier
- p. 602-621.e2
Pineal Region Tumors
- 6 October 2017
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 83 (4) , 732-739
Post-Traumatic Hydrocephalus in Children: A Retrospective Study in 42 Pediatric Hospitals Using the Pediatric Health Information System
BACKGROUND: Post-traumatic hydrocephalus (PTH) is a potentially treatable cause of poor recovery from traumatic brain injury (TBI) that remains poorly understood, particularly among children. OBJECTIVE: To better understand the risk factors for pediatric PTH using a large, multi-institutional database. METHODS: We conducted a retrospective cohort study using administrative data from 42 pediatric hospitals participating in the Pediatric Health Information System. All patients ≤21 yr surviving a hospitalization with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for TBI were identified. The primary outcome was PTH, defined by an ICD-9-CM procedure code for surgical management of hydrocephalus within 6 mo. Data were analyzed using multivariable logistic regression. RESULTS: We identified 91 583 patients ≤21 yr with TBI, 846 of whom developed PTH. Odds of PTH were significantly higher in children <1 yr compared to older age groups. A total of 48.7% of PTH cases were victims of abuse (adjusted odds ratio [aOR] 2.62, 95% confidence interval [CI] 2.16-3.18). PTH was more common after craniotomy (aOR 1.60, 95% CI 1.30-1.97). Craniectomy without early cranioplasty was associated with markedly increased odds of PTH (aOR 3.67, 95% CI 2.66-5.07), an effect not seen in those undergoing cranioplasty within 30 d (aOR 1.19, 95% CI 0.75-1.89). CONCLUSION: PTH was seen in 0.9% of children who sustained a TBI and was more common in those <1 yr. Severe injury, abuse, and craniectomy with delayed cranioplasty were associated with greatly increased likelihood of PTH. Early cranioplasty in children who require craniectomy may reduce the risk for PTH.
- 6 October 2017
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 83 (4) , 732-739
Post-Traumatic Hydrocephalus in Children: A Retrospective Study in 42 Pediatric Hospitals Using the Pediatric Health Information System
BACKGROUND: Post-traumatic hydrocephalus (PTH) is a potentially treatable cause of poor recovery from traumatic brain injury (TBI) that remains poorly understood, particularly among children. OBJECTIVE: To better understand the risk factors for pediatric PTH using a large, multi-institutional database. METHODS: We conducted a retrospective cohort study using administrative data from 42 pediatric hospitals participating in the Pediatric Health Information System. All patients ≤21 yr surviving a hospitalization with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for TBI were identified. The primary outcome was PTH, defined by an ICD-9-CM procedure code for surgical management of hydrocephalus within 6 mo. Data were analyzed using multivariable logistic regression. RESULTS: We identified 91 583 patients ≤21 yr with TBI, 846 of whom developed PTH. Odds of PTH were significantly higher in children <1 yr compared to older age groups. A total of 48.7% of PTH cases were victims of abuse (adjusted odds ratio [aOR] 2.62, 95% confidence interval [CI] 2.16-3.18). PTH was more common after craniotomy (aOR 1.60, 95% CI 1.30-1.97). Craniectomy without early cranioplasty was associated with markedly increased odds of PTH (aOR 3.67, 95% CI 2.66-5.07), an effect not seen in those undergoing cranioplasty within 30 d (aOR 1.19, 95% CI 0.75-1.89). CONCLUSION: PTH was seen in 0.9% of children who sustained a TBI and was more common in those <1 yr. Severe injury, abuse, and craniectomy with delayed cranioplasty were associated with greatly increased likelihood of PTH. Early cranioplasty in children who require craniectomy may reduce the risk for PTH.
- 20 June 2017
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 106 (3) , 1268-1279
Reduced cell attachment to poly(2‐hydroxyethyl methacrylate)‐coated ventricular catheters in vitro
The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure‐prone and over half of all life‐threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2‐hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent‐free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three‐dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X‐ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA‐coated catheters against uncoated clinical‐grade catheters in an in vitro hydrocephalus catheter bioreactor containing co‐cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA‐coated catheters at both 17‐day and 6‐week time points. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268–1279, 2018.
- 20 June 2017
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 106 (3) , 1268-1279
Reduced cell attachment to poly(2‐hydroxyethyl methacrylate)‐coated ventricular catheters in vitro
The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure‐prone and over half of all life‐threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2‐hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent‐free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three‐dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X‐ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA‐coated catheters against uncoated clinical‐grade catheters in an in vitro hydrocephalus catheter bioreactor containing co‐cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA‐coated catheters at both 17‐day and 6‐week time points. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268–1279, 2018.